• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶 1 抑制细胞迁移和侵袭,参与肝癌复发。

Peroxiredoxin 1, restraining cell migration and invasion, is involved in hepatocellular carcinoma recurrence.

机构信息

Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, China.

Francis Family Liver Clinic, University of Toronto & University Health Network, Toronto, Canada.

出版信息

J Dig Dis. 2018 Mar;19(3):155-169. doi: 10.1111/1751-2980.12580.

DOI:10.1111/1751-2980.12580
PMID:29377617
Abstract

OBJECTIVE

Hepatocellular carcinoma (HCC) is a high-burden disease. Peroxiredoxin 1 (PRDX1) is a member of the peroxiredoxin family of antioxidant enzymes. The aim of this study was to assess the value of PRDX1 for predicting HCC recurrence after curative resection and to explore the role of PRDX1 in HCC cell migration and invasion.

METHODS

Data of patients with HCC who had undergone complete resection between 2002 and 2006 were collected. Immunohistochemical detection of PRDX1 in HCC tissue and adjacent non-cancerous tissue was conducted. Kaplan-Meier survival estimate and log-rank test were used to assess the relationship between PRDX1 expression and prognostic significance. HCC cell migration and invasion together with the interaction between PRDX1 and ubiquitin C-terminal hydrolase 37 (UCH37) were studied in vitro.

RESULTS

PRDX1 was expressed at lower levels in HCC tissues than in adjacent non-cancerous tissues, and PRDX1 was found to be an independent risk factor for disease-free survival and overall survival. PRDX1 restrained cell migration and invasion in vitro. PRDX1 was found to interact with UCH37 to affect HCC cell migration and invasion.

CONCLUSION

PRDX1 restrains cell migration and invasion in HCC cell lines and that may be involved in a UCH37-relevant pathway, suggesting that PRDX1 may be a new marker for HCC recurrence after surgery.

摘要

目的

肝细胞癌(HCC)是一种高负担疾病。过氧化物还原酶 1(PRDX1)是抗氧化酶过氧化物还原酶家族的一员。本研究旨在评估 PRDX1 预测根治性切除术后 HCC 复发的价值,并探讨 PRDX1 在 HCC 细胞迁移和侵袭中的作用。

方法

收集 2002 年至 2006 年间接受完全切除术的 HCC 患者的数据。对 HCC 组织和相邻非癌组织中的 PRDX1 进行免疫组织化学检测。采用 Kaplan-Meier 生存估计和对数秩检验评估 PRDX1 表达与预后意义之间的关系。在体外研究 HCC 细胞迁移和侵袭以及 PRDX1 与泛素 C 末端水解酶 37(UCH37)之间的相互作用。

结果

PRDX1 在 HCC 组织中的表达水平低于相邻非癌组织,并且 PRDX1 是无病生存和总生存的独立危险因素。PRDX1 在体外抑制细胞迁移和侵袭。发现 PRDX1 与 UCH37 相互作用影响 HCC 细胞迁移和侵袭。

结论

PRDX1 抑制 HCC 细胞系中的细胞迁移和侵袭,这可能涉及 UCH37 相关途径,表明 PRDX1 可能是手术后 HCC 复发的新标志物。

相似文献

1
Peroxiredoxin 1, restraining cell migration and invasion, is involved in hepatocellular carcinoma recurrence.过氧化物酶 1 抑制细胞迁移和侵袭,参与肝癌复发。
J Dig Dis. 2018 Mar;19(3):155-169. doi: 10.1111/1751-2980.12580.
2
Ubiquitin C-terminal Hydrolase 37, a novel predictor for hepatocellular carcinoma recurrence, promotes cell migration and invasion via interacting and deubiquitinating PRP19.泛素羧基末端水解酶37是肝细胞癌复发的一种新型预测指标,它通过与PRP19相互作用并使其去泛素化来促进细胞迁移和侵袭。
Biochim Biophys Acta. 2013 Mar;1833(3):559-72. doi: 10.1016/j.bbamcr.2012.11.020. Epub 2012 Dec 4.
3
The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.MMP-9 相对于 MMP-2 在 HCC 侵袭性和肝癌根治性切除术后复发中的意义。
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S375-84. doi: 10.1245/s10434-011-1836-7. Epub 2011 Jun 17.
4
Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma.犬尿氨酸3-单加氧酶的预后意义及其对人肝细胞癌增殖、迁移和侵袭的影响
Sci Rep. 2015 Jun 23;5:10466. doi: 10.1038/srep10466.
5
Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma.过氧化物酶 1 表达在人肝细胞癌中的诊断和预后意义。
Med Oncol. 2014 Jan;31(1):786. doi: 10.1007/s12032-013-0786-2. Epub 2013 Dec 3.
6
Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.活化的Cdc42相关激酶1(Ack1)的过表达预示着人类肝细胞癌的肿瘤复发和不良预后。
Pathol Res Pract. 2014 Dec;210(12):787-92. doi: 10.1016/j.prp.2014.09.014. Epub 2014 Oct 6.
7
Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.纤连蛋白-5通过下调基质金属蛋白酶-7的表达来抑制肝癌细胞的迁移和侵袭。
BMC Cancer. 2014 Dec 12;14:938. doi: 10.1186/1471-2407-14-938.
8
Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.膜联蛋白A4的过表达提示预后不良,并促进肝细胞癌的肿瘤转移。
Tumour Biol. 2016 Jul;37(7):9343-55. doi: 10.1007/s13277-016-4823-6. Epub 2016 Jan 16.
9
MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker.丝裂原活化蛋白激酶相互作用激酶 1 促进肝癌的增殖和侵袭,是一个不利的预后生物标志物。
Med Sci Monit. 2018 Mar 26;24:1759-1767. doi: 10.12659/msm.909012.
10
Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.羧肽酶E是早期肝细胞癌肿瘤复发的预测标志物。
Tumour Biol. 2016 Jul;37(7):9745-53. doi: 10.1007/s13277-016-4814-7. Epub 2016 Jan 23.

引用本文的文献

1
Influences The Occurrence and Progression of Liver Cancer by Inhibiting Mitochondrial Apoptosis Pathway.通过抑制线粒体凋亡途径影响肝癌的发生和发展。
Cell J. 2022 Nov 2;24(11):657-664. doi: 10.22074/cellj.2022.8159.
2
Research Progress of DUB Enzyme in Hepatocellular Carcinoma.去泛素化酶在肝细胞癌中的研究进展
Front Oncol. 2022 Jun 27;12:920287. doi: 10.3389/fonc.2022.920287. eCollection 2022.
3
The Prognostic Role of Glutathione and Its Related Antioxidant Enzymes in the Recurrence of Hepatocellular Carcinoma.谷胱甘肽及其相关抗氧化酶在肝细胞癌复发中的预后作用。
Nutrients. 2021 Nov 14;13(11):4071. doi: 10.3390/nu13114071.
4
Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma.PRDXs 基因家族在肝细胞癌中的表达和预后作用。
J Transl Med. 2021 Mar 26;19(1):126. doi: 10.1186/s12967-021-02792-8.
5
Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer.泛素羧基末端水解酶与人类恶性肿瘤:对头颈部癌的新预后及治疗意义
Front Oncol. 2021 Jan 29;10:592501. doi: 10.3389/fonc.2020.592501. eCollection 2020.
6
Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma.开发和验证与 CTNNB1 相关的用于肝细胞癌的代谢预后模型。
J Cell Mol Med. 2021 Jan;25(2):1151-1165. doi: 10.1111/jcmm.16181. Epub 2020 Dec 9.
7
Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer.过氧化物还原酶-1的上调促进宫颈癌细胞增殖和转移并抑制其凋亡。
J Cancer. 2020 Jan 1;11(5):1170-1181. doi: 10.7150/jca.37147. eCollection 2020.
8
The Prognosis Of Peroxiredoxin Family In Breast Cancer.过氧化物还原酶家族在乳腺癌中的预后
Cancer Manag Res. 2019 Nov 14;11:9685-9699. doi: 10.2147/CMAR.S229389. eCollection 2019.
9
Silencing of Xeroderma Pigmentosum Group D Gene Promotes Hepatoma Cell Growth by Reducing P53 Expression.沉默着色性干皮病组 D 基因通过降低 P53 表达促进肝癌细胞生长。
Med Sci Monit. 2018 Nov 9;24:8015-8021. doi: 10.12659/MSM.910944.